Inventor · disambiguated record
Andrew Raymon Morton Bradbury
Also filed as: BRADBURY ANDREW RAYMON MORTON
9 granted patents·4 pending applications·0 citations·filing 2019–2024
79Inventor score
Top patents by PatentIndex Score
13 records- 0180US12351946B2Antibody libraries with maximized antibody developability characteristicsRULES BASED MEDICINE INC·Filed 2024·Granted Jul 8, 2025·0 cites·12 claims
- 0280US12351945B2Antibody libraries with maximized antibody developability characteristicsRULES BASED MEDICINE INC·Filed 2024·Granted Jul 8, 2025·0 cites·9 claims
- 0380US12344959B2Antibody libraries with maximized antibody developability characteristicsRULES BASED MEDICINE INC·Filed 2024·Granted Jul 1, 2025·0 cites·5 claims
- 0479US12359346B2Antibody libraries with maximized antibody developability characteristicsRULES BASED MEDICINE INC·Filed 2024·Granted Jul 15, 2025·0 cites·8 claims
- 0579US2024384437A1Antibody libraries with maximized antibody developability characteristicsRULES BASED MEDICINE INC·Filed 2024·Application pending·0 cites
- 0676US12442107B2Single domain antibody libraries with maximized antibody developability characteristicsRULES BASED MEDICINE INC·Filed 2024·Granted Oct 14, 2025·0 cites·4 claims
- 0772US11920258B2Antibody libraries with maximized antibody developability characteristicsSPECIFICA INC·Filed 2021·Granted Mar 5, 2024·0 cites·12 claims
- 0872US11254931B2Antibody libraries with maximized antibody developability characteristicsSPECIFICA INC·Filed 2021·Granted Feb 22, 2022·0 cites·13 claims
- 0970US12359345B2Single domain antibody libraries with maximized antibody developability characteristicsRULES BASED MEDICINE INC·Filed 2023·Granted Jul 15, 2025·0 cites·5 claims
- 1070US10954508B2Antibody libraries with maximized antibody developability characteristicsSPECIFICA INC·Filed 2019·Granted Mar 23, 2021·0 cites·8 claims
- 1157US2024309095A1Anti-b7-h4 antibodies and uses thereofINCYTE CORP·Filed 2022·Application pending·0 cites
- 1255US2024384438A1Antibody affinity maturation using natural liability-free cdrsRULE BASED MEDICINE INC·Filed 2022·Application pending·0 cites
- 1355US2023167165A1Antibody affinity maturation using natural liability-free cdrsSPECIFICA INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Raymon Morton Bradbury files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →